Advertisement
Screener

X4 PHARMACEUTICALS, INC (XFOR) Patents: Active

X4 PHARMACEUTICALS, INC Active Patents

18 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2025-07-15: Application 19269675; Invention METHODS FOR TREATING NEUTROPENIA; Applicant X4 Pharmaceuticals, Inc.; Status Patented Case.
  • 2025-03-31: Application 19096210; Invention METHODS FOR TREATING NEUTROPENIA; Applicant X4 Pharmaceuticals, Inc.; Status Patented Case.
  • 2023-05-04: Application 18312484; Invention COMPOSITIONS OF CXCR4 INHIBITORS AND METHODS OF PREPARATION AND USE; Applicant X4 Pharmaceuticals, Inc.; Status Patented Case.
  • 2022-09-09: Application 17941509; Invention METHODS FOR TREATING NEUTROPENIA; Applicant X4 Pharmaceuticals, Inc.; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2025-07-1519269675METHODS FOR TREATING NEUTROPENIAX4 Pharmaceuticals, Inc.Patented Case2026-09-0812728125US20250339423A1
E. Lynne Kelley
Sarah Cohen
United States
United States
CORNET, JEAN P
2025-03-3119096210METHODS FOR TREATING NEUTROPENIAX4 Pharmaceuticals, Inc.Patented Case2025-08-0512377090US20250248991A1
E. Lynne Kelley
Sarah Cohen
United States
United States
CORNET, JEAN P
2023-05-0418312484COMPOSITIONS OF CXCR4 INHIBITORS AND METHODS OF PREPARATION AND USEX4 Pharmaceuticals, Inc.Patented Case2024-10-1512115156US20240058322A1
Karel Marie Joseph BRANDS
Italy
SEAMAN, D MARGARET M
2022-09-0917941509METHODS FOR TREATING NEUTROPENIAX4 Pharmaceuticals, Inc.Patented Case2025-04-2912285424US20230014231A1
E. Lynne KELLEY
Sarah COHEN
United States
United States
CORNET, JEAN P
2022-03-1417654722CXCR4 INHIBITORS AND USES THEREOFX4 Pharmaceuticals, Inc.Patented Case2023-10-1011780837US20220372032A1
Elyse Marie Josee BOURQUE
Renato SKERLJ
Canada
United States
KOSACK, JOSEPH R
2021-06-2517359391COMPOSITIONS OF CXCR4 INHIBITORS AND METHODS OF PREPARATION AND USEX4 Pharmaceuticals, Inc.Patented Case2023-06-1311672793US20220008410A1
Karel Marie Joseph Brands
United States
SEAMAN, D MARGARET M
2020-07-2716939723CXCR4 INHIBITORS AND USES THEREOFX4 Pharmaceuticals, Inc.Patented Case2022-04-1911306088US20210047320A1
Elyse Marie Josee Bourque
Renato Skerlj
Canada
United States
KOSACK, JOSEPH R
2020-02-2816804863METHODS FOR TREATING IMMUNODEFICIENCY DISEASEX4 Pharmaceuticals, Inc.Patented Case2022-01-1111219621US20200268739A1
Robert D. Arbeit
Paula Marie Ragan
United States
United States
RAO, SAVITHA M
2019-12-0516704302COMPOSITIONS OF CXCR4 INHIBITORS AND METHODS OF PREPARATION AND USEX4 Pharmaceuticals, Inc.Patented Case2021-06-2911045461US20200253953A1
Karel Marie Joseph Brands
United States
SEAMAN, D MARGARET M
2018-12-2116229223MDR E. COLI SPECIFIC ANTIBODYX4 PHARMACEUTICALS (AUSTRIA) GMBHPatented Case2021-03-0910940191US20190111121A1
Eszter NAGY
Gábor NAGY
Valéria SZIJÁRTO
Zoltán MAGYARICS
Irina MIRKINA
Luis GUACHALLA
Adriana BADARAU
Gerhild ZAUNER
Jolanta LUKASIEWICZ
Austria
Hungary
Austria
Austria
Austria
Austria
Austria
Austria
Poland
GANGLE, BRIAN J
2018-12-1816311083CXCR4 INHIBITORS AND USES THEREOFX4 Pharmaceuticals, Inc.Patented Case2021-04-2710988465US20200255414A1
Elyse Marie Josee Bourque
Renato Skerlj
United States
United States
STOCKTON, LAURA LYNNE
2018-12-1816311055CXCR4 INHIBITORS AND USES THEREOFX4 Pharmaceuticals, Inc.Patented Case2022-05-1711332470US20190322671A1
Elyse Marie Josee Bourque
Renato Skerlj
United States
United States
WARD, PAUL V
2018-12-1816311020CXCR4 INHIBITORS AND USES THEREOFX4 Pharmaceuticals, Inc.Patented Case2020-09-0110759796US20200123150A1
Elyse Marie Josee Bourque
Renato Skerlj
United States
United States
KOSACK, JOSEPH R
2018-12-1116215963COMPOSITIONS OF CXCR4 INHIBITORS AND METHODS OF PREPARATION AND USEX4 Pharmaceuticals, Inc.Patented Case2020-02-0410548889
Karel Marie Joseph Brands
United States
SEAMAN, D MARGARET M
2018-10-0516091689METHODS FOR TREATING CANCERX4 Pharmaceuticals, Inc.Patented Case2022-05-2411337969US20190160051A1
Robert D. Arbeit
United States
KOSTURKO, GEORGE W
2018-06-2216065470METHODS FOR TREATING IMMUNODEFICIENCY DISEASEX4 Pharmaceuticals, Inc.Patented Case2020-04-0710610527US20190083485A1
Robert D. Arbeit
Paula Marie Ragan
United States
United States
RAO, SAVITHA M
2017-08-1715551813ANTIBODIES TARGETING A GALACTAN-BASED O-ANTIGEN OF K. PNEUMONIAEX4 PHARMACEUTICALS (AUSTRIA) GMBHPatented Case2022-10-1111466074US20180066041A1
Valeria SZIJÁRTO
Gábor NAGY
Luis GUACHALLA
Zehra VISRAM
Eszter NAGY
Jolanta Katarzyna LUKASIEWICZ
Austria
Hungary
Austria
Austria
Austria
Poland
DEVI, SARVAMANGALA
2016-12-0915373528MDR E. COLI SPECIFIC ANTIBODYX4 PHARMACEUTICALS (AUSTRIA) GMBHPatented Case2019-02-1910206992US20170087236A1
Eszter NAGY
Gábor NAGY
Valéria SZIJÂRTO
Zoltàn MAGYARICS
Irina MIRKINA
Luis GUACHALLA
Adriana BADARAU
Gerhild ZAUNER
Jolanta LUKASIEWICZ
Austria
Hungary
Austria
Austria
Austria
Austria
Austria
Austria
Poland
GANGLE, BRIAN J

Similar stocks

Stock NameCountryMarket CapPE Ratio
Inhibikase Therapeutics, Inc. (IKT)United States$0.296B-4.44
SAB Biotherapeutics, Inc. (SABS)United States$0.306B-25.49
Century Therapeutics, Inc. (IPSC)United States$0.306B-4.02
Liminatus Pharma, Inc. (LIMN)United States$0.282B
FATE THERAPEUTICS INC (FATE)United States$0.280B-2.51
Lexeo Therapeutics, Inc. (LXEO)United States$0.278B-4.19
PALISADE BIO, INC. (PALI)United States$0.275B-11.41
Invivyd, Inc. (IVVD)United States$0.270B-2.42
SUTRO BIOPHARMA, INC. (STRO)United States$0.260B-3.05
Ocugen, Inc. (OCGN)United States$0.343B-6.34